Efficacy, safety and tolerability of a halobetasol 0.01%/tazarotene 0.045% fixed combination in the treatment of severe plaque psoriasis: Post hoc analysis of 2 phase III randomized controlled trials
期刊名称Journal of the American Academy of Dermatology